Fig. 1From: Cost-effectiveness of umeclidinium compared with tiotropium and glycopyrronium as monotherapy for chronic obstructive pulmonary disease: a UK perspectiveCost-effectiveness scatter plots for a UMEC versus TIO and b UMEC versus GLY, lifetime horizon. GL, glycopyrronium, QALY quality-adjusted life year, TIO tiotropium, UMEC umeclidiniumBack to article page